These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 38498034)
21. [Myelodysplastic syndrome--its natural history, clinical course and diagnosis]. Weryńska B Pol Tyg Lek; 1989 Oct 2-16; 44(40-42):867-71. PubMed ID: 2487939 [No Abstract] [Full Text] [Related]
22. Clonal architecture of secondary acute myeloid leukemia. Walter MJ; Shen D; Ding L; Shao J; Koboldt DC; Chen K; Larson DE; McLellan MD; Dooling D; Abbott R; Fulton R; Magrini V; Schmidt H; Kalicki-Veizer J; O'Laughlin M; Fan X; Grillot M; Witowski S; Heath S; Frater JL; Eades W; Tomasson M; Westervelt P; DiPersio JF; Link DC; Mardis ER; Ley TJ; Wilson RK; Graubert TA N Engl J Med; 2012 Mar; 366(12):1090-8. PubMed ID: 22417201 [TBL] [Abstract][Full Text] [Related]
23. Clinical utility of bone marrow culture. Moore MA Hamatol Bluttransfus; 1976; 19():79-90. PubMed ID: 795748 [TBL] [Abstract][Full Text] [Related]
24. Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromes. Sahoo SS; Pastor VB; Goodings C; Voss RK; Kozyra EJ; Szvetnik A; Noellke P; Dworzak M; Starý J; Locatelli F; Masetti R; Schmugge M; De Moerloose B; Catala A; Kállay K; Turkiewicz D; Hasle H; Buechner J; Jahnukainen K; Ussowicz M; Polychronopoulou S; Smith OP; Fabri O; Barzilai S; de Haas V; Baumann I; Schwarz-Furlan S; ; Niewisch MR; Sauer MG; Burkhardt B; Lang P; Bader P; Beier R; Müller I; Albert MH; Meisel R; Schulz A; Cario G; Panda PK; Wehrle J; Hirabayashi S; Derecka M; Durruthy-Durruthy R; Göhring G; Yoshimi-Noellke A; Ku M; Lebrecht D; Erlacher M; Flotho C; Strahm B; Niemeyer CM; Wlodarski MW Nat Med; 2021 Oct; 27(10):1806-1817. PubMed ID: 34621053 [TBL] [Abstract][Full Text] [Related]
25. The Effects of Human BDH2 on the Cell Cycle, Differentiation, and Apoptosis and Associations with Leukemia Transformation in Myelodysplastic Syndrome. Yang WC; Lin SF; Wang SC; Tsai WC; Wu CC; Wu SC Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32344823 [TBL] [Abstract][Full Text] [Related]
26. Molecular mechanisms involved in the progression of myelodysplastic syndrome. Nolte F; Hofmann WK Future Oncol; 2010 Mar; 6(3):445-55. PubMed ID: 20222800 [TBL] [Abstract][Full Text] [Related]
27. An MDS-derived cell line and a series of its sublines serve as an in vitro model for the leukemic evolution of MDS. Kida JI; Tsujioka T; Suemori SI; Okamoto S; Sakakibara K; Takahata T; Yamauchi T; Kitanaka A; Tohyama Y; Tohyama K Leukemia; 2018 Aug; 32(8):1846-1850. PubMed ID: 29955132 [No Abstract] [Full Text] [Related]
28. Myelodysplastic syndrome progression to acute myeloid leukemia at the stem cell level. Chen J; Kao YR; Sun D; Todorova TI; Reynolds D; Narayanagari SR; Montagna C; Will B; Verma A; Steidl U Nat Med; 2019 Jan; 25(1):103-110. PubMed ID: 30510255 [TBL] [Abstract][Full Text] [Related]
29. Heterogeneous patterns of CEBPalpha mutation status in the progression of myelodysplastic syndrome and chronic myelomonocytic leukemia to acute myelogenous leukemia. Shih LY; Huang CF; Lin TL; Wu JH; Wang PN; Dunn P; Kuo MC; Tang TC Clin Cancer Res; 2005 Mar; 11(5):1821-6. PubMed ID: 15756005 [TBL] [Abstract][Full Text] [Related]
30. How predictive is the finding of clonal hematopoiesis for the development of myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML)? Steensma DP Best Pract Res Clin Haematol; 2021 Dec; 34(4):101327. PubMed ID: 34865699 [TBL] [Abstract][Full Text] [Related]
31. Myelodysplastic syndromes: preleukemic or early leukemic conditions? Dörmer P Haematol Blood Transfus; 1990; 33():3-7. PubMed ID: 2323634 [No Abstract] [Full Text] [Related]
32. Myelodysplastic Syndromes: How to Recognize Risk and Avoid Acute Myeloid Leukemia Transformation. Hospital MA; Vey N Curr Oncol Rep; 2020 Jan; 22(1):4. PubMed ID: 31974774 [TBL] [Abstract][Full Text] [Related]
33. Clonal evolution of preleukemic hematopoietic stem cells precedes human acute myeloid leukemia. Jan M; Snyder TM; Corces-Zimmerman MR; Vyas P; Weissman IL; Quake SR; Majeti R Sci Transl Med; 2012 Aug; 4(149):149ra118. PubMed ID: 22932223 [TBL] [Abstract][Full Text] [Related]
34. Mechanisms underlying the heterogeneity of myelodysplastic syndromes. Dussiau C; Fontenay M Exp Hematol; 2018 Feb; 58():17-26. PubMed ID: 29175473 [TBL] [Abstract][Full Text] [Related]
35. Germline GATA2 Mutation and Bone Marrow Failure. McReynolds LJ; Calvo KR; Holland SM Hematol Oncol Clin North Am; 2018 Aug; 32(4):713-728. PubMed ID: 30047422 [TBL] [Abstract][Full Text] [Related]
36. Genetic predisposition to myelodysplastic syndrome and acute myeloid leukemia in children and young adults. Babushok DV; Bessler M; Olson TS Leuk Lymphoma; 2016; 57(3):520-36. PubMed ID: 26693794 [TBL] [Abstract][Full Text] [Related]
37. Enforced differentiation of Dnmt3a-null bone marrow leads to failure with c-Kit mutations driving leukemic transformation. Celik H; Mallaney C; Kothari A; Ostrander EL; Eultgen E; Martens A; Miller CA; Hundal J; Klco JM; Challen GA Blood; 2015 Jan; 125(4):619-28. PubMed ID: 25416276 [TBL] [Abstract][Full Text] [Related]
38. Preleukemia. Cytogenetic clues in some confusing disorders. Nowell PC Am J Pathol; 1977 Nov; 89(2):459-76. PubMed ID: 335894 [TBL] [Abstract][Full Text] [Related]
39. Myelodysplastic syndrome that progressed to acute myelomonocytic leukemia with eosinophilia showing peculiar chromosomal abnormality: a case report. Kim SH; Suh C; Choi SJ; Kim JG; Lee JH; Kim SB; Kim SW; Lee KH; Lee JS; Kim WK; Kim SH; Seo EJ; Chi HS J Korean Med Sci; 1999 Aug; 14(4):448-50. PubMed ID: 10485627 [TBL] [Abstract][Full Text] [Related]
40. Mechanisms of leukemic transformation in congenital neutropenia. Link DC Curr Opin Hematol; 2019 Jan; 26(1):34-40. PubMed ID: 30431463 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]